Background: Contrast-enhanced imaging has revolutionized diagnostic radiology by improving tissue characterization, lesion detection, and clinical decision-making across multiple medical specialties. Despite its substantial diagnostic benefits, the administration of contrast media is associated with potential adverse effects that require careful patient selection and risk assessment.

Aim: To evaluate the clinical applications, diagnostic benefits, and adverse outcomes associated with contrast-enhanced imaging through a retrospective case series.

Methods: This retrospective case series reviewed nine clinically significant cases involving iodinated contrast media, gadolinium-based contrast agents, microbubble ultrasound contrast agents, and barium sulfate. Cases were selected from documented clinical reports representing cardiovascular, neurological, abdominal, oncological, and contrast-related adverse event scenarios. Clinical presentations, imaging findings, management strategies, and patient outcomes were analyzed descriptively.

Results: Contrast-enhanced imaging significantly improved diagnostic accuracy and clinical management across all evaluated cases. Cardiovascular cases highlighted the occurrence of contrast-induced nephropathy in high-risk patients, while neurological imaging demonstrated improved delineation of glioblastoma margins and successful identification of contrast-induced encephalopathy. Contrast-enhanced ultrasound accurately characterized hepatic lesions, and barium studies effectively diagnosed esophageal carcinoma. Significant adverse events included fatal anaphylaxis, severe contrast extravasation injury, and nephrogenic systemic fibrosis following repeated exposure to linear gadolinium agents. Early recognition, hydration protocols, contrast optimization, and appropriate agent selection contributed to improved clinical outcomes in most cases.

Conclusion: Contrast-enhanced imaging remains an indispensable component of modern diagnostic practice. Although associated with potential complications, appropriate risk stratification, preventive measures, and the use of safer contrast agents can maximize diagnostic benefits while minimizing patient harm.

Keywords: Contrast Media, Contrast-Enhanced Imaging, Contrast-Induced Nephropathy, Gadolinium-Based Contrast Agents, Nephrogenic Systemic Fibrosis, Contrast-Enhanced Ultrasound, Adverse Reactions, Diagnostic Radiology, Case Series, Patient Safety.